Skip to main content
Frontiers in Cellular and Infection Microbiology logoLink to Frontiers in Cellular and Infection Microbiology
. 2021 Mar 8;11:639620. doi: 10.3389/fcimb.2021.639620

A Comparative Transcriptome Analysis of Human and Porcine Choroid Plexus Cells in Response to Streptococcus suis Serotype 2 Infection Points to a Role of Hypoxia

Alexa N Lauer 1, Rene Scholtysik 2, Andreas Beineke 3, Christoph Georg Baums 4, Kristin Klose 5, Peter Valentin-Weigand 6, Hiroshi Ishikawa 7, Horst Schroten 1, Ludger Klein-Hitpass 2, Christian Schwerk 1,*
PMCID: PMC7982935  PMID: 33763387

Abstract

Streptococcus suis (S. suis) is an important opportunistic pathogen, which can cause septicemia and meningitis in pigs and humans. Previous in vivo observations in S. suis-infected pigs revealed lesions at the choroid plexus (CP). In vitro experiments with primary porcine CP epithelial cells (PCPEC) and human CP epithelial papilloma (HIBCPP) cells demonstrated that S. suis can invade and traverse the CP epithelium, and that the CP contributes to the inflammatory response via cytokine expression. Here, next generation sequencing (RNA-seq) was used to compare global transcriptome profiles of PCPEC and HIBCPP cells challenged with S. suis serotype (ST) 2 infected in vitro, and of pigs infected in vivo. Identified differentially expressed genes (DEGs) were, amongst others, involved in inflammatory responses and hypoxia. The RNA-seq data were validated via quantitative PCR of selected DEGs. Employing Gene Set Enrichment Analysis (GSEA), 18, 28, and 21 enriched hallmark gene sets (GSs) were identified for infected HIBCPP cells, PCPEC, and in the CP of pigs suffering from S. suis ST2 meningitis, respectively, of which eight GSs overlapped between the three different sample sets. The majority of these GSs are involved in cellular signaling and pathways, immune response, and development, including inflammatory response and hypoxia. In contrast, suppressed GSs observed during in vitro and in vivo S. suis ST2 infections included those, which were involved in cellular proliferation and metabolic processes. This study suggests that similar cellular processes occur in infected human and porcine CP epithelial cells, especially in terms of inflammatory response.

Keywords: next generation sequencing, Streptococcus suis, meningitis, choroid plexus, host-pathogen interaction, blood-cerebrospinal fluid barrier

Introduction

The Gram-positive bacterium Streptococcus suis (S. suis) is an important opportunistic zoonotic pathogen, of which serotype 2 (ST2) is the most prevalent among invasive isolates from the natural host, the pig, as well as for humans (Goyette-Desjardins et al., 2014). The most common clinical manifestation for pigs and humans is meningitis, but septicemia, endocarditis, arthritis, pneumonia, and peritonitis are also reported. Noteworthy, S. suis is considered as a re-emerging pathogen especially in Asian countries (Lun et al., 2007; Dutkiewicz et al., 2017; Dutkiewicz et al., 2018).

Previous observations made in natural and experimentally in vivo infected pigs revealed that S. suis infections are associated with lesions at the choroid plexus (CP) (Sanford, 1987; Williams and Blakemore, 1990; Beineke et al., 2008). The CP forms an interface between the blood and the central nervous system (CNS), the so-called blood-cerebrospinal fluid barrier (BCSFB). The main barrier property at the CP results from the polarized epithelial cells, which are connected via tight junctions and tight junction-associated proteins, such as ZO1 and occludin (Wolburg et al., 2001). Experiments performed in vitro using primary porcine CP epithelial cells (PCPEC) or immortal human CP epithelial papilloma (HIBCPP) cells demonstrated that S. suis can invade and traverse the CP epithelial cells. As a consequence, challenging the CP with S. suis contributes to the immunological response via cytokine and chemokine expression and secretion (Tenenbaum et al., 2008; Schwerk et al., 2011; Schwerk et al., 2012).

Some efforts have been made to investigate the response of host cells and organisms to infection with S. suis. Previous in vitro studies involving infection of different cell types with S. suis, such as human brain microvascular endothelial cells (HBMEC) or immune cells, including THP-1 monocytes, J774 macrophages, and dendritic cells, have focused on host-pathogen interaction, the inflammatory response and intracellular signaling of the host cells, or on bacterial survival and their interaction with host cells (Charland et al., 2000; Segura et al., 2002; Segura et al., 2004; Meijerink et al., 2012). Whole transcriptome analyses on host cells after challenge with S. suis have been performed using THP-1 monocytes, porcine alveolar macrophages, and primary porcine choroid plexus epithelial cells (PCPEC) (De Greeff et al., 2010; Liu et al., 2011b; Schwerk et al., 2011). Differentially expressed genes (DEGs) identified during these studies belonged to different functional categories. Amongst others, genes involved in immune response and host defense, apoptosis/programmed cell death, and those involved in signal transduction pathways were found to be overrepresented (De Greeff et al., 2010; Liu et al., 2011b; Schwerk et al., 2011).

Approaches to investigate the host response to S. suis in vivo have been performed in several organisms, including pigs (Li et al., 2010; Liu et al., 2011a; Gaur et al., 2014; Ye et al., 2017), but also non-porcine species, such as zebrafish and mice (Wu et al., 2010; Rong et al., 2012). Confirming the results of in vitro challenged host cells, during these studies genes involved in inflammatory and immune defense responses were identified as DEGs (Li et al., 2010; Liu et al., 2011a; Rong et al., 2012; Ye et al., 2017). Tissues and organs investigated during the porcine in vivo studies covered spleen, brain, lung, monocytes, and peritoneal blood, but not specifically the CP. Therefore, the transcriptomic changes at the CP of pigs suffering from meningitis after infection with S. suis are unknown, leaving participating target genes and host signaling pathways open for discovery. Furthermore, a comparative analysis of the transcriptional response at the CP, either after infection in vitro vs. in vivo, or between human and porcine model systems, has not yet been performed. Due to the function of the CP as entry gate into the CNS during infection with S. suis, and its role during inflammatory responses to the pathogen, transcriptome analyses of infected pigs and CP epithelial cell cultures will reveal important differently regulated genes that play a role during these processes and point to the cellular pathways involved.

In this study, we employed next generation sequencing (RNA-seq) to compare changes in global transcriptome profiles caused by S. suis SS2 at the CP of infected pigs in vivo, as well as in PCPEC and HIBCPP cells infected in vitro. Identified DEGs and enriched hallmark gene sets (GSs) point to involvement of cellular signaling, immune and inflammatory responses, and hypoxia, whereas cellular proliferation and metabolic processes are rather suppressed during infection. Additionally, the inflammatory responses appear to involve similar cellular processes in infected human and porcine CP epithelial cells.

Materials and Methods

Ethics Statement

In vivo piglet infection experiments, and the subsequent necropsy, were carried out by veterinarians, in compliance with the principles outlined in the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, as well as the German Animal Protection Law (Tierschutzgesetz). The CP tissue samples analyzed in this study originated from two different in vivo infection studies. The CP tissue samples from the meningitis-free animals were part of a study, which was approved by the Landesdirektion Sachsen, with the permit number TVV28/16, which includes approval through the registered committee for animal experiments. The experiment analyzing the CP from animals suffering from meningitis were approved by the Committee on Animal Experiments of the Lower Saxonian State Office for Consumer Protection and Food Safety under the permit number 33.12-42,502-04-16/2305A (Rungelrath et al., 2018). The piglets of both studies originated from the same German Landrace herd that is based on the genotyping results of more than 400 S. suis isolates free of the S. suis pathotype investigated in this study.

In Vivo Porcine Infection Experiments

The CP tissue samples used for the transcriptome analysis were collected from two independent in vivo porcine infection experiments using approximately 8-week-old German Landrace pigs. The animals, from which “meningitis-free” samples were obtained, were three 8-week-old male piglets intravenously infected with 2 × 108 colony forming units (CFU) of S. suis ST7 strain 13-00283-02 in the 5th week of life within an unpublished experimental infection. The three piglets, from which “meningitis” samples were obtained, were experimentally infected with S. suis ST2 strain 10. Experimental infection was conducted in anesthesia of 8-week-old male piglets via intranasal application of 1.5 × 109 CFU following a treatment with 1% acetic acid of the mucosal surface of the nasal cavity as part of a published study carried out by Rungelrath and colleagues (Rungelrath et al., 2018).

In both experiments, the animals were monitored and examined every 8 h post-infection for the onset of disease and were given a clinical score, based on their body temperature, food uptake, and overall behavior (alertness, breathing pattern, mobility). An animal was considered morbid if it presented with a fever of at least 40.2°C. If a high fever persisted (at least 40.5°C), along with apathy and/or anorexia over a 36 h time period, the piglet was euthanized for predefined animal welfare reasons. Additionally, if the piglet presented severe clinical signs, such as opisthotonus, convulsions, inability to rise, or acute polyarthritis, the animal was subject for immediate euthanasia.

Onset of severe disease usually occurred 3 to 5 days post-infection. Once a predefined humane endpoint was reached, the animal was anesthesised through application of 2 mg azaperone (Stresnil®, Firma Yanssen) and 10 mg ketamine hydrochloride (Ursotamin®, Serumwerke Bernburg) per kg body weight intramuscularly and subsequently euthanized via the intravenous administration of T61® (200 mg ml−1 embutramide, 50 mg ml−1 mebezonium, and 5 mg ml−1 tetracain; Intervet, Merck, Sharp & Dohme). The “meningitis-free” piglets were euthanized the same way after observation of 23 days following the experimental ST7 infection.

Immediately following the euthanasia of each animal, a necropsy was performed, which has been previously described by Baums and colleagues (Baums et al., 2006). Additionally, the brain was promptly removed and cut between the two brain hemispheres in order to gain access to the lateral ventricles. One of the two CP from the lateral ventricles was removed, briefly rinsed in sterile DPBS, and flash-frozen in liquid nitrogen for subsequent RNA isolation and transcriptome analysis.

Cell Culture

Human choroid plexus papilloma (HIBCPP) cells have been described previously as in vitro model of the BCSFB (Schwerk et al., 2012). HIBCPP cells were cultivated in DMEM/F12 (Ham) medium with 4 mM L-glutamine and 15 mM HEPES, supplemented with 100 U/ml penicillin, 100 U/ml streptomycin, and 5 μg/ml insulin (HIBCPP medium) and containing 15% FCS. For infection assays cells were seeded on ThinCert™ cell culture filter membranes (Greiner Bio-One, Frickenhausen, Germany), with a 3 μm pore diameter, a pore density of 2.0 × 106 pores per cm2, and a membrane diameter of 0.33 cm2, in the inverted BCSFB model and maintained as previously described (Schwerk et al., 2012; Dinner et al., 2016), with some modifications. Briefly, a maximum of 100,000 cells were seeded on the membrane of inverted cell culture filter inserts, which, when confluent, resulted in approximately 400,000 cells per filter. HIBCPP cells up to passage 38 were used for experiments. The following day filter membranes were flipped, and placed hanging into a 24-well cell culture plate. The cells were supplied with HIBCPP cell culture medium containing 10% FCS that was exchanged every second day. Approximately 3 to 4 days post-seeding TEER values were monitored with an epithelial tissue voltohmmeter (Millipore, Schwalbach, Germany). Once a TEER of at least 70 Ω x cm2 was reached, cells were transferred to HIBCPP cell medium containing 1% FCS. For infection experiments, filters with a TEER of at least 240 Ω x cm2 and a maximum of 740 Ω x cm2 were used, which was reached 1 or 2 days later.

The isolation and culture of primary PCPEC was performed as previously described (Gath et al., 1997; Haselbach et al., 2001) with some modifications. Briefly, CP tissue was collected from the lateral ventricle of freshly slaughtered pigs at the meat-processing center, and subjected to treatment with 0.2% trypsin (Biochrom, Berlin, Germany, 45 min at 4°C, 17 min at 37°C). Following this cold/warm trypsin treatment, 1 volume of pre-warmed FCS was added before the cell suspension (undigested CP tissue was removed) was centrifuged for 10 min at 55 × g at room temperature, and the pellet was resuspended in 10 ml DMEM (1×) with GlutaMAX™ (Gibco Life Technologies, Paisley, UK) with 4.5 g L−1 D-Glucose, pyruvate, and phenol red, 2% (v/v) P/S, and 0.05% (v/v) human recombinant insulin solution (Sigma-Aldritch, Steinheim, Germany) (PCPEC medium) containing 10% FCS and 20 µM Cytosine Arabinoside (AraC, Cell Pharm GmbH, Hannover, Germany). Subsequently, 100 μl of the cell suspension was seeded on the membrane of inverted ThinCert™ cell culture filter inserts (Greiner Bio-One, Frickenhausen, Germany), which were pre-coated with mouse laminin. The following day the filters were washed once by flipping and hanging the cell culture filter membranes into a 24-well cell culture plate containing pre-warmed DPBS (containing Ca2+ and Mg2+) in order to remove non-adherent cells. Cells were then cultivated for 4 days in PCPEC medium containing 10% FCS and 20 µM AraC, followed by cell culture in AraC-free medium with a medium change every 2 days. Starting 6 days post-seeding, the TEER development was monitored with an epithelial tissue voltohmmeter (Millipore, Schwalbach, Germany). Once the TEER reached approximately 100 Ω x cm2, the cells were transferred to PCPEC medium without FCS. A confluent primary PCPEC layer on the 24-well cell culture filter membrane consisted of approximately 60,000 cells. For infection experiments filters with a TEER of at least 250 Ω x cm2 were used.

Measurement of Barrier Integrity

In order to evaluate the barrier development and barrier integrity of HIBCPP cells and PCPEC, the TEER was measured by utilizing a voltohmmeter coupled with a chopstick STX01 electrode (Millipore, Schwalbach, Germany). To calculate the resistance across the cell culture filter membrane area (Ω x cm2), the measured Ω, from which the blank value was subtracted (cell culture membrane filter not containing any cells) was multiplied by the surface area of the 24-well cell culture filter membrane (approximately 0.336 cm2).

In order to monitor the paracellular permeability of HIBCPP cells and PCPEC throughout the infection intervals, the permeability for FITC-coupled inulin was determined as previously described (Schwerk et al., 2012).

Bacterial Strains and Cultivation

S. suis ST2 strain 10, kindly provided by Hilde Smith (Lelystad, NL), has been used in various studies for experimental induction of disease including meningitis (Vecht et al., 1992; Smith et al., 1999). S. suis ST7 strain 13-00283-02 belongs to sequence type 29 and has recently been characterized (Rieckmann et al., 2018). The genomes of both strains have been sequenced (Bunk et al., 2021). Bacteria were cultivated in liquid Todd Hewitt Broth (THB; Oxoid, Wesel, Germany) in order to prepare bacteria stocks for long-term storage and infection experiments. The medium for long-term preservation at −80°C was composed of bacteria suspended in DMEM/F-12 (1×) medium (containing L-Glutamine, 15 mM HEPES, without phenol red; Gibco/Life Technologies™, Paisley, UK) with an optical density at 600 nm (OD600) of 0.65, containing 20% glycerol (Sigma-Aldrich, Steinheim, Germany).

In order to cultivate bacteria for the infection experiments, long-term storage stock aliquots were added to 10 ml Todd Hewitt Broth (THB) and incubated at 37°C to mid-log phase. Subsequently, bacterial cultures were washed twice with the appropriate medium used during the infection experiment (see above). The bacterial cell suspension was adjusted to an OD600 of 0.65, which resulted in approximately 2 × 108 CFU ml−1.

In order to determine the bacterial CFU, which was used for infection of host cells in vitro, as well as the CFU throughout the infection time points, the inoculum and an amount, which equaled a multiplicity of infection (MOI) of 10, was serial diluted and plated in duplicate onto Colombia sheep blood agar plates (Oxoid, Wesel, Germany). The sheep blood agar plates were incubated inverted in a humidified incubator at 37°C and 5% CO2 overnight, and the CFU were counted the following day.

In Vitro Infection Experiments

HIBCPP cells and PCPEC were infected in vitro with S. suis ST2 strain 10 once the TEER values reached at least 250 Ω×cm2. Infection was performed with a MOI of 10. The HIBCPP cells were infected up to 10 h, with time points being in 2 h increments. The primary PCPEC were infected up to 6 h, again, with time increments being in 2 h. Throughout the infection time points, TEER values and paracellular permeability were determined to evaluate barrier integrity.

Cell Viability—Live/Dead Assay

To determine the cell viability of PCPEC and HIBCPP cells live/dead-assays (Invitrogen, Karlsruhe, Germany) were performed according to the manufacturer’s instructions. In this assay living cells appear green (intracellular esterase activity), whereas dead cells appear red (loss of plasma membrane integrity allows entry and DNA binding of ethidium homodimer-1). Results were documented by immunofluorescence microscopy.

RNA Isolation

The RNeasy Mini Kit (Qiagen, Hilden, Germany) was used for total RNA isolation from HIBCPP cells and the CP tissue from the in vivo porcine experiments. For the HIBCPP cell infection experiments, filters were briefly rinsed with DPBS (with Ca2+ and Mg2+), before the cells were processed following the manufacturers protocol “purification of total RNA from animal cells using spin technology.” For the CP tissue collected from the in vivo porcine infection experiments, 30 mg of fresh-frozen CP tissue was suspended in 600 μl lysis buffer and homogenized using a micro pestle. Subsequently, the homogenized tissue suspension was applied to a QiaShredder column (Qiagen, Hilden, Germany) before RNA was isolated according to the manufacturer’s protocol “purification of total RNA from animal tissues.” The RNeasy Micro Kit (Qiagen, Hilden, Germany) was used for total RNA isolation from PCPEC. Lysates from four cell culture membranes were pooled. The manufacturer’s protocol “purification of total RNA from animal and human cells” was followed. All isolated RNA samples underwent an on-column DNase I treatment (15 min incubation at room temperature), which was integrated during the RNA isolation protocols, as described by the manufacturer (Qiagen, Hilden, Germany). Following the isolation, RNA samples were eluted in RNase-free H2O and stored at −80°C. The RNA concentration was determined with a spectrophotometer (ND1000, Peqlab Biotechnoloy, Erlangen, Germany).

Semiquantitative RT-PCR and QPCR

Total RNA (0.5 μg RNA from HIBCPP cells and from the CP tissue from the in vivo porcine infection experiments; 0.125 μg from PCPEC) was reverse transcribed using random primers included in the AffinityScript QPCR cDNA Synthesis Kit (Agilent Technologies). Semi-quantitative PCR reactions applying defined volumes of the generated cDNA were performed with the Taq DNA Polymerase Kit (Qiagen) following the manufacturers’ instructions. PCR reaction mixtures were initially denatured for 2 min at 94°C and subsequently subjected to the indicated cycles of denaturation (94°C, 30 s), annealing (55–60°C, depending on the primers, 30 s), and extension (72°C, 1 min) followed by a final extension step at 72°C for 7 min. PCR products were visualized by gel electrophoresis using 1.5% agarose gels and ethidium bromide staining.

To quantitatively evaluate the expression of selected genes, the Brilliant II SYBR® Green QPCR Master Mix kit (Agilent Technologies) was used according to the manufacturer’s instructions. The qPCR was run using the Stratagene Mx3005P system with the MX software using the one plateau pre-melt/RT segment and normal two-step amplification setting, followed by determination of a dissociation curve. The following conditions were applied: initial denaturation (95°C, 10 min) followed by 40 cycles of denaturation (95°C, 30 s), combined annealing and extension (58°C, 60 s), and the denaturation curve (95°C, 60 s; 65°C, 30 s; 95°C, 30 s). Fold-changes were calculated using the 2−ΔΔCt method (Livak and Schmittgen, 2001) and expression of the gene for Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as control.

Primers for RT-PCR and QPCR were designed employing Primer3 software (Rozen and Skaletsky, 2000) and are shown in Supplementary Tables S1 and S2 , respectively. The primer sequences were synthesized by Sigma-Aldrich (Steinheim, Germany), delivered in a lypophilic form, and reconstituted in double-distilled water.

RNA-Seq Analyses

RNA samples used for RNA-seq analysis were evaluated for their RNA integrity with the Agilent 2100 Bioanalyzer System (Agilent Technologies, Waldbronn, Germany) in combination with the Agilent Bioanalyzer RNA Nano Chip. RNA integrity numbers were above 9.5 for RNA isolated from HIBCPP cells, above 8.9 for RNA isolated from PCPEC, and above 7.4 for RNA isolated from CP tissues obtained during the in vivo porcine infection experiments.

The Ovation® Human FFPE RNA-Seq Multiplex System Kit (NuGen, Illumina, San Diego, CA, USA) was utilized for library preparation from 100 ng of total RNA from the HIBCPP cells for conventional RNA-seq. For the PCPEC and the porcine CP tissues from the in vivo infection experiments, the Universal Plus mRNA-Seq kit (NuGen, Illumina, San Diego, CA, USA) was used for the RNA library preparation from 100 ng total RNA.

For transcript fragmentation the Covaris S220 Focused-ultrasonicator, with the Covaris microTUBE, set to 10% duration, 200 cycles per burst, and 140 s was used to generate fragment sizes of approximately 250 bp long. Fragment lengths were analyzed on the Agilent 2100 Bioanalyzer System using the Agilent Bioanalyzer HS DNA chip. Bead-purification steps were carried out with the help of Agencourt AMPure XP SPRI beads in order to remove adapter or primer dimers throughout the various cDNA synthesis, adaptor ligation, or PCR amplification steps. The Qubit system was used in combination with the double stranded DNA high sensitivity assay kit in order to determine the DNA concentration of the prepared libraries before these were pooled. Adaptor ligation introduces specific 8 bp long barcode sequence to each of the individual biological replicates of infected and uninfected samples. With the use of the barcodes, one library pool containing all the biological replicates for each phenotype (infected and uninfected) was generated for sequencing. The library pool was quantified utilizing the NEBNext® Library Quant kit, which is a SYBR Green based qPCR method essential in order to achieve the optimal cluster density on the sequencing flow cell required for an optimal sequencing output.

The sequencing of the pooled HIBCPP cell sample set library was performed using HiSeq 2500 flow cell system (Illumina®, San Diego, CA, USA) in the high-output and paired-end mode. The sequencing of the pooled RNA libraries of the PCPEC samples and the in vivo CP samples was carried out on the HiSeq 2500 flow cell system (Illumina®, San Diego, CA, USA) in the rapid-run and paired-end mode, sequencing 100 bp length for each read.

Bioinformatic Processing Post-Sequencing

Subsequently to the sequencing process, the generated raw reads were processed. In a first step the adapter sequences were removed with the help of the Trimmomatic-0.30 software tool, which was designed to identify full and partial adapter sequences from single- and paired-end Illumina NGS data (Bolger et al., 2014). The trimmed sequences were subject to alignment by utilizing the RNA aligner STAR software (Dobin et al., 2013). The sequences generated from the HIBCPP cells were aligned to the human genome 19 and the sequences generated from the porcine samples (PCPEC and CP tissue from the in vivo infection experiments) were aligned to the Sus scrofa genome 11.1. The aligned sequences of the HIBCPP cell and PCPEC samples were imported into the StrandNGS software and filtered on quality metrics, which included the removal of reads that had more than one match, an alignment score of below 95, mapping quality below 40, and lengths less than 20. This additional filtering step was not carried out on the sequences aligned from the in vivo experiment. Instead, these sequences were subject to Universal Molecular Identifiers filtering, which resulted in less than 5% of reads removed. These aligned and filtered reads can be imported to the Integrative Genomics Viewer, which allows visualization of the NGS datasets (Robinson et al., 2011).

Lastly, for the quantification of the RNA sequences, the aligned and filtered reads were imported to the Partek Genomics Suite (PartekGS) software. This software reports the reads per kilobase of exon model per million reads (RPKM), which is a scaling method applied in order to normalize the RNA abundancies for sequencing depth (library size) and gene length (Mortazavi et al., 2008).

RNA-Seq Statistical Data Analysis: DEGs and GSEA

In order to evaluate the differential gene expression and to utilize data analysis platforms for downstream analysis, RPKM values and/or the raw reads were used to generate the Differentially Expressed Genes (DEGs) list and to perform a Gene Set Enrichment Analysis (GSEA). DEGs were identified using the PartekGS software implementing the one-way analysis of variance (ANOVA) test. A step-up method to correct for multiple testing was applied to generate corrected p-values, but due to the low number of replicates, the correction for multiple testing eliminated many potential true-positive targets. For this reason, the identification of DEGs was based on uncorrected p-values. The resulting p-values were exported and further manual filtering steps were carried out in Excel from Microsoft Office. Filters, which were applied in order to generate the final DEG list, included at least 10 (for the PCPEC and in vivo samples) or 20 (for the HIBCPP cell samples) raw reads of the transcript in the biological triplicates of one class (uninfected versus infected) and an uncorrected p-value of ≤0.05. Additionally, a more stringent list was created which only displayed a list of significant DEGs with a corrected (step-up method) p-value ≤0.05 (De and Baron, 2012). The genes resulting in the final DEG list with an uncorrected and corrected p-value ≤0.05 were taken into consideration.

A second statistical analysis was applied using the RPKM values, by utilizing the GSEA software, which allows the user to interpret the data on a biological relevant gene set level, and not on individual genes, when comparing different biological states (Mootha et al., 2003; Subramanian et al., 2005). The GSEA makes use of the Molecular Signature Database (MSigDB), which contains approximately 18,000 gene sets (GSs), categorized into eight major groups (Subramanian et al., 2005; Liberzon et al., 2011; Liberzon et al., 2015). The GSEA was run with the standard settings in the gene set permutation mode, set to 1,000 permutations. In order to select potential interesting candidates, GSs which presented a false discovery rate (FDR) q-value ≤0.25 were considered to be of interest, along with a normalized enrichment score (NES) of approximately ±2.

Accession Numbers

The data generated during RNA-seq was deposited in the Sequence Read Archive (SRA) on the National Center for Biotechnology Information (NCBI) platform. The BioProject accession number for the HIBCPP cell data is PRJNA533919. The BioProject accession number for the PCPEC data is PRJNA533792. The BioProject accession number for the data acquired from the CP tissue which was isolated following the in vivo infection experiments and sequenced via conventional RNA-seq is PRJNA534398.

Statistics

The significance of the gene fold change from infected samples in comparison to uninfected samples was calculated using the unpaired student’s t-test. A result was considered significant if p ≤ 0.05.

Results

Infection of HIBCPP Cells and PCPEC With S. suis ST2

We have previously shown that S. suis ST2 invades both HIBCPP cells and PCPEC in a polar fashion from the basolateral side and that the CP contributes to the inflammatory response when challenged with S. suis (Tenenbaum et al., 2009; Schwerk et al., 2011; Schwerk et al., 2012). To determine time points following infection of HIBCPP cells and PCPEC, at which the cells demonstrate a transcriptional response, we treated cells grown on inverted cell culture filter inserts with S. suis ST2 for different amounts of time and analyzed the expression of selected inflammatory response genes by semi-quantitative RT-PCR ( Figure 1 and data not shown). As shown in Figure 1A both HIBCPP cells and PCPEC displayed a strong transcriptional response after 6 h of challenge with S. suis ST2. Importantly, the barrier function of both HIBCPP cells and PCPEC stayed intact during this time period as indicated by a stable TEER ( Figure 1B ) and low permeability by FITC-labelled inulin ( Figure 1C ). Furthermore, live/dead assays demonstrated that both cell types remained viable during the infection period (data not shown). Therefore, we selected HIBCPP cells and PCPEC infected with S. suis ST2 for 6 h in the inverted cell culture insert model for further transcriptome analyses.

Figure 1.

Figure 1

Infection of HIBCPP cells (left) and PCPEC (right) with S. suis ST2 (indicated as Ss) causes induction of an inflammatory response. (A) HIBCPP cells and PCPEC grown on inverted cell culture filter inserts were treated with S. suis ST2 at a MOI of 10 for 6 h and semi-quantitative RT-PCR was performed to determine induction of the genes indicated at the left of the panels. PCR reactions were analyzed after the cycle numbers indicated at the top of the panels. Uninfected HIBCPP cells and PCPEC served as controls (B) TEER values of uninfected control cells and of infected HIBCPP cells and PCPEC were measured at the beginning of the experiments (0 h) and after 6 h of infection (6 h). (C) The flux of FITC-labelled inulin across uninfected control cells and across infected HIBCPP cells and PCPEC was measured after 6 h of infection and stayed below 6% (dotted lines) under all conditions.

The CP of In Vivo Infected Piglets Suffering From Meningitis Exhibited an Inflammatory Response

In vivo infection experiments with S. suis were carried out with 8-week-old piglets. Three meningitis-free control animals intravenously infected with S. suis ST7 3 weeks prior euthanasia and three animals suffering from meningitis after intranasal infection with S. suis ST2 strain 10 (Rungelrath et al., 2018) were selected for further analysis.

The meningitis-free animals exhibited no clinical signs of central nervous system dysfunction within the entire observation period. Following the conclusion of the experiment, the animals were euthanized and a necropsy was performed. Part of the necropsy consisted of CSF, swabs, and tissue collections for bacteriological investigations and preserving respective predefined tissues in formalin for histopathological evaluation as described elsewhere (Baums et al., 2006; Rungelrath et al., 2018). No bacterial growth was observed on Columbia blood agar plates used for cultivation of CSF and brain swabs. Furthermore, the absence of fibrinous and purulent inflammations in the brain, meninges and the CP was confirmed for the three animals included in this study. These results are summarized in Table 1 .

Table 1.

Summary of the clinical signs, the specific bacterial loads of CSF, and the histopathological lesions in the brain found in piglets post-infection with S. suis ST7 (piglets 17, 24, and 43) and ST2 (piglets 4, 5, and 34).

Animal Number Symptoms post-infection Bacterial CFU per ml of CSF Histopathological findings
Meningitis-free animals1
17 Day 1: 40.4°C fever
Day 2: no fever
None No fibrinous or purulent lesion in the brain, meninges, or CP
24 Day 1: 41.1°C then 40.4°C fever
Day 2: 40.7°C fever, which cleared by the end of the day
None No fibrinous or purulent lesion in the brain, meninges, or CP
43 Day 1: 41.1°C then 41.3°C
Day 2: 41.3°C, which cleared by the end of the day
Day 14: 40.3°C, which cleared by the end of the day
None No fibrinous or purulent lesion in the brain, meninges, or CP
Animals suffering from meningitis2
4 42.1°C fever, ataxia, kyphosis, body tremors, abdominally reinforced breathing 3.33 × 107 Moderate multifocal fibro-purulent meningitis and moderate multifocal plexus chorioiditis
5 41°C fever, ataxia, body tremors, convulsions 5.43 × 107 High grade multifocal fibro-purulent meningitis and moderate multifocal plexus chorioiditis
34 41.7°C fever, body tremors, abdominal reinforced breathing, nystagmus, opisthotonus 3.03 × 107 Moderate multifocal fibro-purulent meningitis (no comment on the state of the CP)

1Piglets were euthanized after observation of 23 days following the experimental ST7 infection.

2Piglets were euthanized for predefined animal welfare reasons if a high fever persisted (at least 40.5°C), along with apathy and/or anorexia over a 36 h time period or if severe clinical signs, such as opisthotonus, convulsions, inability to rise, or acute polyarthritis were presented.

The onset of clinical signs in the animals infected with S. suis ST2 occurred 2 to 4 days post-infection, and included high fever, body tremors, convulsions, and ataxia. Due to the severeness and character of these clinical signs these piglets reached the humane endpoint were euthanized. As with the meningitis-free animals, part of the necropsy consisted of CSF, swab and tissue collection and preserving the tissues in formalin for histopathological evaluation. The CSF of all three animals showed a high amount of bacterial CFUs per ml of CSF, which were confirmed via MP-PCR (Silva et al., 2006) to be mrp+ epf+ sly+ cps2+ S. suis (data not shown). The two piglets (5, 34) which exhibited specific central nervous system dysfunctions and piglet 4 with high fever and tremors were found post-mortem to have a fibro-purulent meningitis via histopathological evaluation of the brain and CP as summarized in Table 1 .

RNA isolation was performed from one CP of the lateral ventricles in the selected animals. A semi-quantitative RT-PCR was performed in order to confirm an inflammatory response at the CP of in vivo S. suis ST2 infected piglets compared to meningitis-free pigs. As depicted in Figure 2 , the CP isolated from piglets suffering from meningitis showed a clear inflammatory response by the increased expression (enhanced signal when referencing the GAPDH signal) of the genes encoding IL1β and IL8, as compared to the meningitis-free piglets. The signal for the CXCL2 expression, in contrast, was only enhanced for some piglets suffering from meningitis. GAPDH was used as a house-keeping gene, which displayed a non-coherent expression likely due to either the heterogeneous cell population found in the CP tissue or lower RNA integrities compared to RNA from the in vitro infection experiments ( Figure 2 ).

Figure 2.

Figure 2

The choroid plexus of S. suis ST2 in vivo infected piglets shows an inflammatory response in comparison to piglets not suffering from meningitis. Semi-quantitative RT-PCR was performed to determine induction of the genes indicated at the left of the panels and PCR reactions were analyzed after the cycle numbers indicated at the top of the panels. Animals 17, 24, and 43 were meningitis-free, whereas animals 4, 5, and 34 suffered from meningitis.

Bioinformatic Processing of RNA-Seq Data Revealed Efficient Mapping to Exon Gene Regions

The RNA samples from S. suis ST2 challenged HIBCPP cells and PCPEC and control cells as well as from CPs isolated from meningitis-free pigs or from pigs suffering from meningitis were subjected to RNA-seq as described in Materials and Methods. Following the sequence run, the generated reads were aligned to either the human or the porcine reference genome with the RNA aligner STAR (Dobin et al., 2013) and quantified in PartekGS.

In total, approximately 20 million reads were generated per sample of the HIBCPP cell sample set and for the samples originating from the in vivo infection experiments, and approximately 10 million reads were generated for the PCPEC samples.

For the HIBCPP cell samples, approximately 62–74% of the aligned reads fully overlapped to an exon region of the reference genome (data not shown). The aligned reads obtained from the samples of porcine origin (in vitro and in vivo samples) displayed a higher full exon overlap, of approximately 80%.

The quality assurance for the transcript alignment and mapping post-sequencing displayed values within acceptable ranges (data not shown) for all samples which underwent sequencing and alignment and were statistically analyzed in the next step.

Differentially Expressed Genes (DEGs)

We first determined the magnitude of statistically significant DEGs based on the number of reads detected during the alignment and mapping process. A total of 1,479 significant (p ≤ 0.05) DEGs were identified following the analysis of S. suis ST2 infected versus uninfected HIBCPP cells. A total of 63 DEGs were identified, which exhibited at least a 2-fold up- or down-regulation, of which 32 genes displayed an up-regulation and 31 genes displayed a down-regulation. The results of the uncorrected p-values are presented in Supplementary Table S3 , while the correction of the p-value yielded no significantly DEGs (data not shown). The highest significant up-regulation observed was a 3.6 fold change for the gene encoding for ZFPL36L1. The strongest down-regulation was observed for the microRNA3648 with an 8-fold change. Interestingly, the majority of the genes only exhibited a 2- to 3-fold differential expression following the 6 h infection period with S. suis ST2.

For the in vitro S. suis ST2 infected PCPEC samples, a total of 430 genes were identified as significantly differentially regulated with an uncorrected p-value ≤0.05, of which 46 genes exhibited an up-regulation of at least 2-fold, and 4 genes a down-regulation of at least 2-fold. The results of the uncorrected p-values are presented in Supplementary Table S4 , since the correction of the p-value yielded only one significant gene (ACOD1; p = 0.025; data not shown). Interestingly, the in vitro infected primary PCPEC displayed a very strong cellular response during the infection with S. suis ST2, with a maximum of 134-fold up-regulation for IL1β. A total of 21 genes exhibited an up-regulation of at least 3-fold, with the majority of these genes known to being involved in the inflammatory response and regulation. In contrast, a total of only four genes encoding for VSIG4, DLGAP5, KNL1, and STRC were significantly differentially down-regulated at least 2-fold during S. suis ST2 infection. The gene encoding for STRC was the highest significantly down-regulated gene, which exhibited a maximum down-regulation of 3-fold change.

A total of 3,355 DEGs with an uncorrected p-value of ≤0.05 were identified in the CP of pigs suffering from S. suis ST2—induced meningitis in relation to meningitis-free pigs. The DEG list of significant genes with a corrected p-value ≤0.05 presented 479 genes, which were at least ±2-fold regulated, of which 171 genes were up-regulated and 308 genes were down-regulated (data not shown). Due to this large number, the significant DEGs with corrected p-values are presented in Supplementary Table S5 . In total, 30 genes which were significantly differentially regulated exhibited a fold change of at least ±2 with a corrected p-value of ≤0.05. Twelve of the 30 genes displayed an up-regulation and 18 genes displayed a down-regulation. The strongest up-regulation was 11.3-fold for the gene encoding INSM1, whereas the strongest down-regulation was 6.3-fold for the gene encoding for TIMD4. Furthermore, of the 30 genes identified in Supplementary Table S5 , 13 genes exhibited a fold change ±3.

Only two overlapping significant DEGs were identified in the infected CP epithelial cells, HIBCPP cells and PCPEC, and included transcriptional and immune response regulator (TCIM) and Rho family GTPase 1 (RND1).

Verification of Selected Genes by qPCR

Following the sequencing analysis, the generated data was validated by verifying the expression levels of selected genes by qPCR. The DEG lists presented in Differentially Expressed Genes (DEGs) were used in order to select candidate genes for the validation of the sequencing data. Genes, which are implicated during inflammation [IL1β, IL8, C-X-C ligand 2 chemokine (CXCL2), TNFα] and during regulation of the inflammatory response [NFκB inhibitor alpha (NFκBIA), zinc finger CCCH-type containing 12A (ZC3H12A), TCIM] were selected for the verification. Additionally, since hypoxia is implicated during bacterial infections (Schaffer and Taylor, 2015; Zeitouni et al., 2016; Devraj et al., 2017), genes known to play a key role during hypoxia, or are known to have their expression influenced in a hypoxic environment (hypoxia-inducible factor 1 alpha (HIF1α), vascular endothelial growth factor a (VEGFA), MAX interactor 1 (MXI1), dual specificity phosphatase 2 (DUSP2)), were chosen for validation.

Table 2 summarizes the fold change and the corresponding significance (uncorrected p-value of a one-way ANOVA test) of the selected genes during the RNA-seq analysis compared to the relative fold change (2−ΔΔCT) between infected versus uninfected samples, along with the S.D., of the qPCR results. Overall, the gene fold change determined following the RNA-seq data analysis could be validated with the qPCR method, and the significances determined following the qPCR analysis largely corresponded to the significant fold change determined in the RNA-seq experiment. Genes encoding for the cytokines and chemokines displayed a higher fold change in the PCPEC and in samples from the porcine in vivo infection experiments, an observation also made from the DEG lists (Differentially Expressed Genes (DEGs)).

Table 2.

Summary of the fold changes and uncorrected p-values of selected genes from the RNA-seq data and the fold changes of infected samples in relation to uninfected samples.

HIBCPP cells PCPEC In vivo
RNA-seq QPCR RNA-seq QPCR RNA-seq QPCR
FC p-value relative 2−ΔΔCt S.D. FC p-value relative 2−ΔΔCt S.D. FC p-value relative 2−ΔΔCt S.D.
IL1β −1.1 0.925 2.0 3.4 134.0 0.041 136.4 83.0 2.8 0.127 4.6 15.3
IL8 3.8 0.386 3.8 7.3 22.6 0.006 20.5 12.8 22.0 0.014 7.6 17.7
CXCL2 4.9 0.258 4.7 5.3 13.8 0.017 19.4 5.5 9.9 0.005 13.0 25.1
TNFα 12.1 0.256 12.0 17.1 70.7 0.006 19.8 2.6 1.1 0.909 1.2 0.3
NFκBIA 4.2 0.266 2.6 3.5 3.9 0.016 3.5 1.2 1.3 0.173 1.7 0.4
ZC3H12A 3.3 0.220 3.1 2.4 2.1 0.004 2.0 1.2 2.9 0.107 1.4 0.6
TCIM 3.1 0.025 2.6 4.6 2.7 0.001 2.7 0.4 2.2 0.114 3.1 1.9
HIF1α 1.1 0.732 0.8 0.3 −1.6 0.306 1.0 0.2 −1.3 0.008 1.0 0.1
VEGFA 2.0 0.075 1.6 0.5 1.6 0.006 1.4 0.3 1.4 0.003 1.4 0.2
MXI1 2.5 0.043 2.8 12.1 1.2 0.008 1.0 0.03 1.1 0.416 1.1 0.1
DUSP2 −2.6 0.015 −4.2 2.2 5.2 0.016 1.3 1.5 8.1 0.004 9.7 1.9

The fold changes and p-values of the RNA-seq data were determined by the software PartekGS. The fold change for the qPCR data was calculated via the 2−ΔΔCT method using GAPDH as an internal control, and the relative fold change was determined between infected versus uninfected samples with the S.D. Genes are considered significantly differentially regulated if the p-value ≤0.05. These listed genes were selected for subsequent QPCR validation.

FC, fold change; S.D., standard deviation.

Identification of Enriched Individual Genes by GSEA

A GSEA was performed in order to evaluate the data in terms of biologically relevant functions. In addition to attributing enriched genes to pre-defined GSs, GSEA also evaluated the individual genes for their enrichment and how well their expression differentiates in the two phenotypes. Figure 3 depicts the heat-map generated in the GSEA analysis of the top 50 genes, which were found to be most distinguishing between S. suis ST2 infected epithelial cells or animals suffering from meningitis and uninfected epithelial cells or meningitis-free animals. The strongest coherent differential expression between the biological triplicates for each phenotype can be observed for the samples, which originated from the porcine in vivo experiments. However, strong coherence was observed for the majority of the biological HIBCPP cells and PCPEC replicates. Furthermore, the majority of the GSEA enriched genes were also identified with the PartekGS software, and can be found in the presented DEG lists in Differentially Expressed Genes (DEGs).

Figure 3.

Figure 3

The GSEA generated heat-map depicts a coherent expression of the biological triplicates for all sample sets of the top 50 ranked genes. Dark red indicates high expression, dark blue indicates low expression.

Overall, the majority of the top 50 enriched genes displayed coherent differentiation in all biological replicates for the investigated phenotype. Interestingly, the top enriched genes determined by the GSEA software were also identified through the DEG analysis performed with the PartekGS software.

Identification of Enriched Hallmark GSs by GSEA

The hallmark GS collection consists of 50 GSs, which represent well-defined and coherent biological states, and were created in order to reduce redundancy. Furthermore, these 50 GSs are divided into eight major biological categories of: cellular components, development, immune reaction, cellular metabolism, pathways, cellular proliferation, signaling, and DNA damage (Liberzon et al., 2015).

The GSEA of analyzed HIBCPP cell samples revealed that a total of 18 GSs out of the 50 hallmark GS collection were found to be significantly enriched in 6 h S. suis ST2 infected cells. Table 3 presents these significantly enriched hallmark GSs, which exhibited a FDR q-value of less than or equal to 0.25. The majority of the GSs can be categorized into cell signaling, and include, for e.g., TNFα signaling via NFκB, IL2-STAT5, and transforming growth factor beta (TGFβ) signaling. Additionally, five GSs belonging to the immune cellular processes were significantly enriched and include, for e.g., inflammatory response, IL6-JAK/STAT3 signaling, and complement system. Furthermore, the most significantly enriched GS was hypoxia (NES 3.24, q-value 0.000), and is categorized into the cellular pathways, along with apoptosis (NES 1.53, q-value 0.032). The GS epithelial-mesenchymal transition (EMT) was the third significantly enriched GS (NES 1.98, q-value 0.001) and belongs to the category of cellular development.

Table 3.

GSEA of 18 hallmark GSs, which are significantly enriched in S. suis ST2 infected HIBCPP cells.

Hallmark Gene Set Name Size NES FDR q-value
Hypoxia 158 3.24 0.000
TNFα Signaling via NFκB 168 2.87 0.000
Epithelial-Mesenchymal transition 112 1.98 0.001
Apical surface 29 1.85 0.002
Glycolysis 171 1.78 0.012
Cholesterol homeostasis 68 1.73 0.012
Inflammatory Response 111 1.69 0.014
IL2-STAT5 Signaling 146 1.60 0.022
Myogenesis 107 1.54 0.030
Apoptosis 126 1.53 0.032
P53 Pathway 177 1.48 0.045
KRAS Signaling_up 124 1.45 0.057
Interferon γ response 159 1.44 0.056
KRAS Signaling_down 70 1.35 0.089
IL6-JAK/STAT3 Signaling 55 1.34 0.090
Allograft rejection 105 1.20 0.210
TGFβ Signaling 48 1.19 0.210
Complement 132 1.19 0.208

The normalized enrichment score (NES) represents the extent of GS enrichment, taking the number of genes (“size”), which compose the GS, into account. The false discovery rate (FDR) is considered significant if q is ≤0.25.

NES, normalized enrichment score; FDR, false discovery rate.

Table 4 summarizes the enriched GSs of the response of the infected PCPEC. A total of 28 GSs were found to be significantly enriched and displayed a FDR of q ≤ 0.25. The majority of enriched GSs are categorized into the cellular signaling and include the GSs, for e.g., TNFα signaling via NFκB, IL2-STAT5, and TGFβ. The category with the second most enriched GSs was found to belong to the immune response and include, for e.g., interferon α, γ, and inflammatory response, IL6-JAK/STAT3 signaling, and complement system. The category containing the third most enriched GSs for the infected or meningitis phenotype was the cellular pathway and included hypoxia, apoptosis, unfolded protein response, and reactive oxygen species pathway. Additionally, the GSs angiogenesis and EMT, which are categorized into cellular development, were found to be enriched.

Table 4.

GSEA of 28 hallmark GSs, which are significantly enriched in infected primary PCPEC.

Hallmark Gene Set Name Size NES FDR q-value
TNFα signaling via NFκB 151 3.12 0.000
Interferon γ response 135 2.49 0.000
Inflammatory response 105 2.48 0.000
Allograft Rejection 108 2.20 0.000
IL6-JAK/STAT3 Signaling 48 2.19 0.000
Hypoxia 146 2.12 0.000
IL2-STAT5 Signaling 129 1.99 0.000
Interferon α response 73 1.90 0.001
Complement 136 1.88 0.001
UV response_up 115 1.87 0.001
Apoptosis 123 1.85 0.002
P53 Pathway 154 1.64 0.016
Coagulation 78 1.54 0.034
Unfolded protein response 93 1.51 0.044
Wnt/β-catenin 31 1.49 0.047
Reactive oxigen species pathway 40 1.47 0.051
Estrogen response_early 136 1.41 0.083
KRAS Signaling_up 127 1.39 0.090
Angiogenesis 23 1.37 0.101
NOTCH Signaling 25 1.36 0.102
KRAS Signaling_down 78 1.28 0.178
TGFβ Signaling 47 1.27 0.177
Xenobiotic Metabolism 129 1.24 0.200
Epithelial-Mesenchymal transition 153 1.24 0.192
Glycolysis 145 1.23 0.195
Cholesterol homeostasis 63 1.23 0.187
Androgen response 86 1.23 0.187
MTORC1 Signaling 162 1.20 0.210

The normalized enrichment score (NES) represents the extent of GS enrichment, taking the number of genes (“size”), which compose the GS, into account. The false discovery rate (FDR) is considered significant if q is ≤0.25.

NES, normalized enrichment score; FDR, false discovery rate.

Table 5 summarizes the enriched GSs of the response of the CP in animals, which suffered from meningitis. In total, 21 GSs were significantly (FDR q ≤ 0.25) enriched. The majority of the GSs belong in the category of cellular signaling, with these GSs being TNFα signaling via NFκB, IL2-STAT5, TGFβ. The GS categories for immune system, cellular development, and cellular pathways all displayed an equal amount of enriched GSs. The inflammatory response, IL6-JAK/STAT3 signaling, and coagulation are categorized as immune response. The GSs angiogenesis, myogenesis, and EMT can be categorized under cellular development, and hypoxia, unfolded protein response, and reactive oxygen species pathway are categorized under cellular pathways.

Table 5.

GSEA of the 21 hallmark GSs, which are significantly enriched in animals suffering from meningitis.

Hallmark Gene Set Name Size NES FDR q-value
TNFα signaling via NFκB 181 2.77 0.000
Inflammatory response 168 1.98 0.001
IL6-JAK/STAT3 Signaling 69 1.82 0.006
IL2-STAT5 Signaling 174 1.79 0.006
TGFβ Signaling 49 1.73 0.008
Hypoxia 167 1.70 0.008
Estrogen response_early 168 1.58 0.020
Androgen response 89 1.52 0.029
Wnt/β-catenin 36 1.52 0.026
UV response_up 133 1.47 0.036
Myc targets 49 1.40 0.059
Angiogenesis 30 1.36 0.074
Cholesterol homeostasis 66 1.35 0.073
UV response_down 129 1.33 0.078
Coagulation 106 1.33 0.074
Estrogen response_late 167 1.33 0.071
Unfolded protein response 94 1.29 0.089
KRAS Signaling_up 174 1.25 0.118
Reactive oxigen species pathway 40 1.24 0.115
Myogenesis 165 1.19 0.172
Epithelial-Mesenchymal transition 178 1.17 0.186

The normalized enrichment score (NES) represents the extent of GS enrichment, taking the number of genes (“size”), which compose the GS, into account. The false discovery rate (FDR) is considered significant if q is ≤ 0.25.

NES, normalized enrichment score; FDR, false discovery rate.

A summary of the significantly enriched GSs designated to the respective cellular processes, as well as the percentage of the designated enriched GSs of the total number of significant GSs, are depicted in Figure 4 .

Figure 4.

Figure 4

Summary of the enriched GSs of the hallmark GSEA for S. suis ST2 infected HIBCPP cells, PCPEC, and pigs. These pie-charts summarize the enriched GSs from Table 4 to Table 6 . The percentage, which is listed under the bold labels indicating the cellular process category, is based on the total number of significantly (FDR q ≤ 0.025) enriched GSs for the sample. The outer labels of the pie chart represent the significantly enriched GS for each sample which falls under the respective cellular process category.

GSs which are enriched in uninfected cells or meningitis-free animals in comparison to the infected or diseased state were also evaluated and are summarized in Table 6 . These GSs display a negative NES score and a FDR q ≤ 0.25. In uninfected HIBCPP cells, the majority of enriched GSs were found to belong to the category of cellular proliferation. Furthermore, an enrichment of GSs belonging to the cellular categories of pathways, DNA damage, and development, was observed.

Table 6.

The hallmark GSs, which are enriched in uninfected cells or meningitis-free animals.

Hallmark Gene Set Name Size NES FDR q-value
uninfected HIBCPP cells
MYC targets V2 58 −2.29 0.000
MYC targets V1 197 −1.90 0.000
E2F targets 197 −1.86 0.000
Unfolded protein response 109 −1.57 0.020
G2M Checkpoint 195 −1.56 0.016
DNA repair 138 −1.50 0.035
Spermatogenesis 64 −1.42 0.075
uninfected PCPEC
E2F Targets 150 −1.54 0.128
Pancreas Beta Cells 18 −1.37 0.245
meningitis-free pigs
Interferon α response 81 −2.57 0.000
Interferon γ response 163 −1.99 0.000
Oxidative phosphorylation 152 −1.72 0.003
E2F Targets 166 −1.62 0.010
DNA Repair 119 −1.40 0.122
Fatty Acid Metabolism 130 −1.38 0.122
Allograft Rejection 173 −1.32 0.186
Bile acid metabolism 97 −1.30 0.202

The normalized enrichment score (NES) represents the extent of GS enrichment, taking the number of genes (“size”), which compose the GS, into account. The false discovery rate (FDR) is considered significant if q is ≤0.25.

NES, normalized enrichment score; FDR, false discovery rate.

The uninfected PCPEC displayed the least amount of significant enriched GSs. Most notable was the GS containing genes regulated by the E2F transcription factors, belonging to the cellular proliferation category displayed a significant enrichment.

The majority of enriched GSs in uninfected cells or meningitis-free pigs are involved in the immune response and cellular metabolism. The interferon α and γ response, as well as the allograft rejection GSs are categorized under immune response, whereas the metabolic processes include oxidative phosphorylation, as well as fatty acid and bile acid metabolism.

Discussion

In this study, the global transcriptome response of in vitro S. suis-infected HIBCPP cells and PCPEC, as well as the CP tissue of in vivo infected piglets with meningitis, was analyzed via RNA-seq. Subsequent to sequencing, the generated data was evaluated on the differential expression of individual genes and was also biologically interpreted by evaluating the enrichment of GSs via the GSEA between the infected versus uninfected phenotypes.

A previous transcriptome investigation, utilizing microarray technology, of apically S. suis ST2 infected PCPEC, which in vivo would reflect the state of infection following bacterial translocation into the CNS, revealed that the CP epithelial cells contributed to the inflammatory response in vitro (Schwerk et al., 2011). The basolateral infection of PCPEC in this current study, which in vivo would reflect the state before bacteria enter the CNS, induced a strong transcriptional response, with the majority of the identified significant DEGs being involved in inflammation as well. Part of the inflammatory response is the upregulation of cytokines and chemokines (including IL1β, TNFα, IL1α, CCL3L1, CXCL8, AMCF-II, CXCL2, CCL2, CCL11, CCL5, and IL6), many of which were also identified in the previous study of apically infected PCPEC (Schwerk et al., 2011). IL1β was found to be the strongest up-regulated gene and is known to be involved in many physiological functions, among others, being a potent inducer of inflammatory signaling expressed by many different cell types, including the CNS (Hewett et al., 2012). In previous studies evaluating the S. suis-dependent cytokine production, IL1β, along with other key inflammatory cytokines, such as IL6 and IL8, was found to be produced by porcine monocytes and polymorphonuclear lymphocytes in a whole-blood system in response to infection, as well as in human THP-1 monocytes (Segura et al., 2002; Segura et al., 2006). Furthermore, utilizing a murine in vivo S. suis infection model, the transcription of IL1β, TNFα, and CCL2 in the brain during cerebral inflammation was demonstrated via in situ hybridization (Dominguez-Punaro et al., 2007). In addition to the cytokine and chemokine upregulation observed in this present work, the inflammatory response regulators SLAMF7, RELB, NFKBIZ, NFKBIA, and ZC3H12A were identified, further underlining the strong inflammatory response elicited by PCPEC during to infection.

The transcriptome of HIBCPP cells was previously investigated following the in vitro infection with N. meningitidis from the basolateral cell side and demonstrated a strong inflammatory response, which included the production of cytokines and chemokines (Borkowski et al., 2014). Studies involving infection of other human cells with S. suis, such as HBMEC or human immune cells, mainly focused their research on the inflammatory response of host cells, too, or on bacterial survival and interaction with host cells (Charland et al., 2000; Segura et al., 2002; Liu et al., 2011b; Meijerink et al., 2012). Interestingly, in this present study, whereas PCPEC displayed a strong inflammatory response to infection, genes attributed to hypoxia were found to play a more prominent role during infection in HIBCPP cells (including ZFP36L1, MXI1, KLHL24, PNRC1, CDKN1C, and DUSP2).

In addition to the hypoxic response, it was interesting to observe the significant differential regulation of various RNA types, which are known to have a regulatory function and are non-protein coding. These regulatory RNAs included the anti-sense RNAs HLA-F, LIFR, PRKAR2A, ZEB1, and long intergenic non-coding RNAs (LINC) 887, 1431, 2482, as well as microRNAs (MIRs) 22HG and 3648, which are associated with viral inflammation and cancer and cellular proliferation, respectively (Rashid et al., 2017; Razooky et al., 2017; Zhang et al., 2018). This suggests that non-coding RNAs play a role in human CP epithelial cells during infection.

In this study, for the first time the transcriptome of cells found at the CP of pigs was investigated. For this sample set, it is important to consider that the CP tissue obtained from the in vivo infected pigs consists of a heterogeneous cell population, such as CP epithelial, endothelial cells, and immune cells located at or recruited to the BCSFB (Strazielle and Ghersi-Egea, 2000). Therefore, the results of the CP tissues samples cannot directly be compared to that of the in vitro infection experiments with homogenous PCPEC and HIBCPP epithelial cell populations. However, this data is rich in information, which helps to understand the CP tissue-specific response during S. suis infection. Previous studies carried out utilizing in vivo porcine S. suis infection models investigated the transcriptome of different organs (brain, lung, monocytes, spleen), but not specifically the CP (Li et al., 2010; Liu et al., 2011a). These studies evaluated the transcriptome at pre-defined time points (24 h and 3 days post-infection) of 4- to 5-week-old piglets, as compared to this present study, where the response of 8-week-old pigs was analyzed which developed acute meningitis, finding differentially regulated genes to be predominantly associated with the host’s inflammatory response.

The identification of biological pathways, in which multiple DEGs are connected to a common or networked performance, is of high interest in understanding cellular processes. Employing GSEA we identified GSs, which were significantly enriched in uninfected samples in comparison to infected samples. The majority of these GSs can be categorized into cellular metabolism or cellular proliferation. The enrichment of these GSs gives insight into metabolic alterations, which occur at the CP during S. suis infection, and is indicative that cellular proliferation is altered or stopped during S. suis ST2 infection. One enriched GS, which contains genes regulated by family members of E2F transcription factors, was found to overlap between all of the samples. The E2F transcription factors are important for the regulation of genes involved in DNA replication and the cell division cycle, and in the context of infection, they were previously investigated during viral infections, such as human immunodeficiency virus and adenovirus (Kundu et al., 1997; Bracken et al., 2004; Zheng et al., 2016).

A total of 28 GSs was identified to be significantly enriched in S. suis-infected PCPEC. The top enriched GSs are implicated in the immune response, complementing the data obtained in the DEG analysis. In a previous transcriptome study analyzing apically S. suis-infected PCPEC cells, Gene Ontology (GO) analysis, which evaluates high through-put data, based on biological processes, molecular functions, and cellular components (Ashburner et al., 2000), also identified many enriched cellular processes to be involved in inflammation, as revealed by the over-represented GO terms for cytokine activity, inflammatory response, defense response, and IκB kinase/NFκB cascade, as well as programmed cell death, which can be induced as a consequence of inflammation (Schwerk et al., 2011).

For the HIBCPP cell samples set, 18 GSs were found to be significantly enriched, with the most significant enrichment being for the GS containing genes in the hypoxia cellular stress response, thereby confirming its corresponding DEG analysis. In addition to the gene enrichment in hypoxia, the GSEA revealed an enrichment of GSs participating in inflammation. A previous GSEA and a GO analysis of N. meningitidis-infected HIBCPP cells revealed a predominant inflammatory response, with cytokine and chemokine activity playing a significant role (Borkowski et al., 2014). Additionally, a GS involved in wound healing was identified (Borkowski et al., 2014), which is often associated with epithelial–mesenchymal transition (EMT). The EMT GS was identified in the present study to be the third most enriched GS in infected HIBCPP cells. In a different study investigating the transcriptome of a human monocyte cell line exposed to S. suis, GO analysis revealed a cellular response including the participation of intracellular signaling pathways involved in inflammation, such as apoptosis and host defense and immunity, as well as other cellular processes involving cellular metabolism, gene transcription, and gene translation (Liu et al., 2011b).

The GSEA of the CP isolated from in vivo-infected piglets identified 21 significantly enriched GSs. The majority of the GSs displayed involvement in the inflammatory host response, as was also observed with the PCPEC samples. A previous porcine in vivo investigation revealed that the brains of S. suis-infected piglets displayed gene enrichment also involved in inflammation, and could be categorized into the GO terms of biological processes responding to a stimulus via signal transducer activity, cytokine activity and binding, defense response, inflammatory response, immune response, and innate immune response (Liu et al., 2011a). However, it was noted that many GO categories overlapped, due to the same genes being involved in multiple biological processes (Liu et al., 2011a). A further transcriptome study utilizing a zebrafish S. suis infection model, underscored the role of inflammation and host defense during infection (Wu et al., 2010).

When comparing the 18, 28, and 21 significantly enriched GSs from S. suis ST2 infected HIBCPP cells, PCPEC, and animals suffering from meningitis, respectively, a total of eight GSs were found to overlap ( Figure 5 ). These included the five GSs TNFα signaling via NFκB, inflammatory response, IL2-STAT5 signaling, IL6-JAK/STAT3 signaling, and TGFβ signaling, which were previously implicated during S. suis infection, whereas the three GSs for hypoxia, EMT, and a set of genes up-regulated by KRAS signaling, were not. Activation of the transcription factor NFκB regulates the expression of genes involved in the inflammatory response, including the expression of cytokines and chemokines, such as TNFα (Liu et al., 2017). An increase of TNFα, along with other pro-inflammatory cytokines, was detected in the brain, blood, and kidney of S. suis-infected mice, as well as in a porcine in vivo infection model, which investigated the brain, mononuclear cells, and lung (Liu et al., 2011a; Nakayama et al., 2011). Furthermore, the virulence associated factor suilysin of S. suis was shown to induce the release of TNFα in human monocytes (Lun et al., 2003) and, by utilizing PCPEC, microarray analysis following S. suis infection from the apical cell side revealed a strong induction of TNFα and other inflammatory cytokines (Schwerk et al., 2011). Interestingly, the release of TNFα was found to promote the permeability in a human BCSFB in vitro model, by inducing cell death (Schwerk et al., 2010). The release of cytokines is known to elicit a downstream cellular signaling cascade. One such signaling cascade is the IL6 induction of JAK/STAT3 signaling, which has been described to influence cell growth and differentiation, and is, therefore, often implicated in cancer when dysregulated (Huynh et al., 2017). Furthermore, as with IL6, IL2 has been described to stimulate the STAT5 signaling cascade, which is known to mainly regulate cellular proliferation and modulate the immune response of T cells (Lin and Leonard, 2000). In the context of S. suis infection, STAT3 and STAT5 were found to be up-regulated in the porcine brain in vivo (Liu et al., 2011a). However, the roles of these signaling cascades during S. suis infection have not been further investigated.

Figure 5.

Figure 5

Overlap of the GSEA identified GSs for S. suis ST2 infected HIBCPP cells, PCPEC, and the CP of pigs suffering from S. suis-induced meningitis. The Venn diagram depicts the number of significantly enriched GSs attributed to each sample set with the number of GSs which were found to overlap between the infected epithelial cells (HIBCPP cells and PCPEC) and the epithelial cells with the in vivo CP tissue from meningitis cases, as well as the number of GSs overlapping between all three samples sets analyzed. Eight GSs were found to overlap in the three analyzed samples sets.

Another well described signaling cascade can be induced by the cytokine TGFβ, which was previously found to be upregulated in the porcine spleen and brain of S. suis in vivo infected piglets (Li et al., 2010; Liu et al., 2011a). The induction of TGFβ signaling was also implicated during the colonization of Streptococcus pneumoniae and Haemophilus influenzae, which are other known bacterial meningitis-causative agents, in lung epithelial cells and was accompanied by an inflammatory response (Beisswenger et al., 2009).

To date, hypoxia, EMT, and genes regulated by KRAS signaling have not been directly linked to S. suis infection. It should be considered that an enrichment of the KRAS GS in this present study was observed due to overlapping genes found with the GS EMT, which is a cellular program that reverts epithelial cells to mesenchymal cells and is often implicated in cancer, since it promotes metastasis and invasion (Kalluri and Weinberg, 2009). EMT is also often involved in wound healing and tissue regeneration, which occurs following a physical trauma or injury caused by inflammation as a result of, e.g., an infection (Kalluri and Weinberg, 2009; Hofman and Vouret-Craviari, 2012). Furthermore, previous studies, especially in cancer research, have demonstrated that a hypoxic environment is a prerequisite in order for EMT to occur (Cannito et al., 2008).

A hypoxic microenvironment is often associated with infected tissues and elicits a stress response due to oxygen being a necessity in order for animal cells to carry out their normal physiological functions (Taylor and Colgan, 2017). Hypoxia has been implicated during injury to the CNS, which includes stroke or infection (van der Flier et al., 2003; Mukandala et al., 2016) and affects the global transcription and translation of mRNA molecules by reducing both of these molecular processes, which allows for energy conservation during cellular stress (Koritzinsky and Wouters, 2007). Since the hypoxia GS was the top significantly enriched GS in the infected HIBCPP samples, it could be speculated as a reason for why the HIBCPP cells did not exhibit a strong fold change in the DEG analysis, as compared to the PCPEC post-infection.

Hypoxia stress response can be induced either in a hypoxia-inducible factor (HIF) dependent or independent manner, most notably via the NFκB transcription factor, with complex overlaps and cross-talks described between these two pathways (Rius et al., 2008; Schaffer and Taylor, 2015). NFκB activation is known to be associated with the acute phase of hypoxia, as well as cytokine release, most notable being IL1β and TNFα (Mukandala et al., 2016). Additionally, IL1β and TNFα can activate the HIF transcription factor in an oxygen-independent and NFκB-dependent pathway during inflammation (Lin and Simon, 2016). Interestingly, the inflammatory cytokine IL1β was observed to affect BBB permeability by influencing blood vessel plasticity via HIF regulation in the angiogenesis program in multiple sclerosis patients (Argaw et al., 2006). A further study investigating the cytokine presence in the CSF of infants who suffered a perinatal hypoxia event, found that infants who displayed an elevated amount of TNFα and IL6 in the CSF, were significantly more likely to suffer from severe neurological abnormalities 12 months post-partum; a phenomenon, which was also observed in survivors of bacterial meningitis and cerebral malaria (John et al., 2008; Perdomo-Celis et al., 2015; Sumanovic-Glamuzina et al., 2017).

Hypoxia does not only induce a cellular stress response, but is also described to modulate cell functions, e.g. of epithelial cells during infection (Schaffer and Taylor, 2015; Taylor and Colgan, 2017). In two previous studies, it was demonstrated that a hypoxic environment during the infection with Pseudomonas aeruginosa of lung epithelial cells reduced the host’s cellular uptake of the pathogen, thereby diminishing host cell death, as well as causing a decline in the invasion of Yersinia enterocolitica into intestinal epithelial cells in vitro (Schaible et al., 2013; Zeitouni et al., 2016). Furthermore, hypoxia also negatively affected the virulence factor expression (Schaible et al., 2017). These studies demonstrate that a hypoxic environment was able to aid in containing the infection.

Here, we observed to our knowledge for the first time, that hypoxia-related cellular processes were significantly increased in relation to S. suis ST2 infection in vitro with human CP epithelial cells and PCPEC, as well as in the in vivo infected porcine CP samples. One gene in particular stood out in the enriched hypoxia GS in all three analyzed samples sets. VEGF was found to be one of the top enriched genes in the hypoxia GS of all analyzed samples (data not shown), which is indicative of angiogenesis, and in turn has been implicated in chronic hypoxia response (Mukandala et al., 2016).

The hypoxia transcription factor HIF has been discussed as a potential target for adjunctive therapy options, with already successful candidates against methicillin-sensitive and -resistant Staphylococcus aureus strains, in order to improve outcome or potentially replace antimicrobial therapeutics due to a rise in microbial resistance (Zinkernagel et al., 2008; Okumura et al., 2012; Santos and Andrade, 2017). Importantly, HIF therapy would not be solely limited to infections, but could also be applied in the setting of cancer treatment or chronic inflammatory disorders (Santos and Andrade, 2017). By investigating the role of hypoxia in the context of S. suis infection, with a focus on the significance of the BCSFB, a long-term aim could be the exploration of alternative therapy options. Those alternative therapy options could potentially limit infection severity, which is often found corresponding to long-term sequelae of survivors, such as full or partial auditory loss frequently associated with S. suis infection in humans, or death.

Data Availability Statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://www.ncbi.nlm.nih.gov/, PRJNA533919; https://www.ncbi.nlm.nih.gov/, PRJNA533792; https://www.ncbi.nlm.nih.gov/, PRJNA534398.

Ethics Statement

In vivo piglet infection experiments, and the subsequent necropsy, were carried out by veterinarians, in compliance with the principles outlined in the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, as well as the German Animal Protection Law (Tierschutzgesetz). The CP tissue samples analyzed in this study originated from two different in vivo infection studies. The CP tissue samples from the meningitis-free animals were part of a study, which was approved by the Landesdirektion Sachsen, with the permit number TVV28/16, which includes approval through the registered committee for animal experiments. The experiment analyzing the CP from animals suffering from meningitis were approved by the Committee on Animal Experiments of the Lower Saxonian State Office for Consumer Protection and Food Safety under the permit number 33.12-42,502-04-16/2305A (Rungelrath et al., 2018). The piglets of both studies originated from the same German Landrace herd that is based on the genotyping results of more than 400 S. suis isolates free of the S. suis pathotype investigated in this study.

Author Contributions

AL, HS, and CS conceived and coordinated the study. AL performed underlying experiments. AB and KK performed histology. CB and PV-W coordinated animal experiments. RS and LK-H performed RNA-seq analysis. AL, RS, and LK-H performed the statistics. CB, PV-W, and HI provided resources. AL, CS, and HS drafted the manuscript. All authors contributed to the article and approved the submitted version.

Funding

Partial financial support of this research was awarded by the Grimminger-Stiftung für Zoonoseforschung (Grimminger Foundation for Zoonotic Research). The animal experiments were financially supported by a grant of the German Research Foundation (DFG BA 4730/3-1) to CB.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We acknowledge the support of Maren von Köckritz-Blickwede and her group in the ST2 experimental infection of piglets used for collecting in vivo samples. We further thank Karoline Rieckmann, Anna Seydel, and Christine Weiße for conducting the ST7 animal experiment.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2021.639620/full#supplementary-material

References

  1. Argaw A. T., Zhang Y., Snyder B. J., Zhao M. L., Kopp N., Lee S. C., et al. (2006). IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 177, 5574–5584.   10.4049/jimmunol.177.8.5574 [DOI] [PubMed] [Google Scholar]
  2. Ashburner M., Ball C. A., Blake J. A., Botstein D., Butler H., Cherry J. M., et al. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29.   10.1038/75556 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baums C. G., Kaim U., Fulde M., Ramachandran G., Goethe R., Valentin-Weigand P. (2006). Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis. Infect. Immun. 74, 6154–6162.   10.1128/IAI.00359-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beineke A., Bennecke K., Neis C., Schroder C., Waldmann K. H., Baumgartner W., et al. (2008). Comparative evaluation of virulence and pathology of Streptococcus suis serotypes 2 and 9 in experimentally infected growers. Vet. Microbiol. 128, 423–430.   10.1016/j.vetmic.2007.10.028 [DOI] [PubMed] [Google Scholar]
  5. Beisswenger C., Lysenko E. S., Weiser J. N. (2009). Early bacterial colonization induces toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect. Immun. 77, 2212–2220.   10.1128/IAI.01224-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bolger A. M., Lohse M., Usadel B. (2014). Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120.   10.1093/bioinformatics/btu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Borkowski J., Li L., Steinmann U., Quednau N., Stump-Guthier C., Weiss C., et al. (2014). Neisseria meningitidis elicits a pro-inflammatory response involving I kappa B zeta in a human blood-cerebrospinal fluid barrier model. J. Neuroinflamm. 11, 163.   10.1186/s12974-014-0163-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bracken A. P., Ciro M., Cocito A., Helin K. (2004). E2F target genes: unraveling the biology. Trends Biochem. Sci. 29, 409–417.   10.1016/j.tibs.2004.06.006 [DOI] [PubMed] [Google Scholar]
  9. Bunk B., Jakóbczak B., Florian V., Dittmar D., Mäder U., Jarek M., et al. (2021). Complete Genome Sequences of Streptococcus suis Pig-Pathogenic Strains 10, 13-00283-02, and 16085/3b. Microbiol. Resour. Announc. 10, e01137–e01220.   10.1128/MRA.01137-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cannito S., Novo E., Compagnone A., Valfre Di Bonzo L., Busletta C., Zamara E., et al. (2008). Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 29, 2267–2278.   10.1093/carcin/bgn216 [DOI] [PubMed] [Google Scholar]
  11. Charland N., Nizet V., Rubens C. E., Kim K. S., Lacouture S., Gottschalk M. (2000). Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect. Immun. 68, 637–643.   10.1128/iai.68.2.637-643.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. De S. K., Baron M. (2012). Step-up and step-down methods for testing multiple hypotheses in sequential experiments. J. Stat. Plann. Inference 142, 2059–2070.   10.1016/j.jspi.2012.02.005 [DOI] [Google Scholar]
  13. De Greeff A., Benga L., Wichgers Schreur P. J., Valentin-Weigand P., Rebel J. M., Smith H. E. (2010). Involvement of NF-kappaB and MAP-kinases in the transcriptional response of alveolar macrophages to Streptococcus suis. Vet. Microbiol. 141, 59–67.   10.1016/j.vetmic.2009.07.031 [DOI] [PubMed] [Google Scholar]
  14. Devraj G., Beerlage C., Brune B., Kempf V. A. (2017). Hypoxia and HIF-1 activation in bacterial infections. Microbes Infect. 19, 144–156.   10.1016/j.micinf.2016.11.003 [DOI] [PubMed] [Google Scholar]
  15. Dinner S., Borkowski J., Stump-Guthier C., Ishikawa H., Tenenbaum T., Schroten H., et al. (2016). A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side. J. Vis. Exp. 111, 54061.   10.3791/54061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dobin A., Davis C. A., Schlesinger F., Drenkow J., Zaleski C., Jha S., et al. (2013). STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21.   10.1093/bioinformatics/bts635 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dominguez-Punaro M. C., Segura M., Plante M. M., Lacouture S., Rivest S., Gottschalk M. (2007). Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J. Immunol. 179, 1842–1854.   10.4049/jimmunol.179.3.1842 [DOI] [PubMed] [Google Scholar]
  18. Dutkiewicz J., Sroka J., Zajac V., Wasinski B., Cisak E., Sawczyn A., et al. (2017). Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part I - Epidemiology. Ann. Agric. Environ. Med. 24, 683–695.   10.26444/aaem/79813 [DOI] [PubMed] [Google Scholar]
  19. Dutkiewicz J., Zajac V., Sroka J., Wasinski B., Cisak E., Sawczyn A., et al. (2018). Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part II - Pathogenesis. Ann. Agric. Environ. Med. 25, 186–203.   10.26444/aaem/85651 [DOI] [PubMed] [Google Scholar]
  20. Gath U., Hakvoort A., Wegener J., Decker S., Galla H. J. (1997). Porcine choroid plexus cells in culture: expression of polarized phenotype, maintenance of barrier properties and apical secretion of CSF-components. Eur. J. Cell Biol. 74, 68–78. [PubMed] [Google Scholar]
  21. Gaur U., Xiong Y. Y., Luo Q. P., Yuan F. Y., Wu H. Y., Qiao M., et al. (2014). Breed-specific transcriptome response of spleen from six to eight week old piglet after infection with Streptococcus suis type 2. Mol. Biol. Rep. 41, 7865–7873.   10.1007/s11033-014-3680-x [DOI] [PubMed] [Google Scholar]
  22. Goyette-Desjardins G., Auger J. P., Xu J., Segura M., Gottschalk M. (2014). Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg. Microbes Infect. 3, e45.   10.1038/emi.2014.45 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Haselbach M., Wegener J., Decker S., Engelbertz C., Galla H. J. (2001). Porcine Choroid plexus epithelial cells in culture: regulation of barrier properties and transport processes. Microsc. Res. Tech. 52, 137–152.   [DOI] [PubMed] [Google Scholar]
  24. Hewett S. J., Jackman N. A., Claycomb R. J. (2012). Interleukin-1beta in Central Nervous System Injury and Repair. Eur. J. Neurodegener. Dis. 1, 195–211. [PMC free article] [PubMed] [Google Scholar]
  25. Hofman P., Vouret-Craviari V. (2012). Microbes-induced EMT at the crossroad of inflammation and cancer. Gut. Microbes 3, 176–185.   10.4161/gmic.20288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Huynh J., Etemadi N., Hollande F., Ernst M., Buchert M. (2017). The JAK/STAT3 axis: A comprehensive drug target for solid malignancies. Semin. Cancer Biol. 45, 13–22.   10.1016/j.semcancer.2017.06.001 [DOI] [PubMed] [Google Scholar]
  27. John C. C., Panoskaltsis-Mortari A., Opoka R. O., Park G. S., Orchard P. J., Jurek A. M., et al. (2008). Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am. J. Trop. Med. Hyg. 78, 198–205. 10.4269/ajtmh.2008.78.198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kalluri R., Weinberg R. A. (2009). The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420–1428.   10.1172/JCI39104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Koritzinsky M., Wouters B. G. (2007). Hypoxia and regulation of messenger RNA translation. Methods Enzymol. 435, 247–273.   10.1016/S0076-6879(07)35013-1 [DOI] [PubMed] [Google Scholar]
  30. Kundu M., Guermah M., Roeder R. G., Amini S., Khalili K. (1997). Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription. J. Biol. Chem. 272, 29468–29474.   10.1074/jbc.272.47.29468 [DOI] [PubMed] [Google Scholar]
  31. Li R., Zhang A., Chen B., Teng L., Wang Y., Chen H., et al. (2010). Response of swine spleen to Streptococcus suis infection revealed by transcription analysis. BMC Genomics 11, 556.   10.1186/1471-2164-11-556 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Liberzon A., Subramanian A., Pinchback R., Thorvaldsdottir H., Tamayo P., Mesirov J. P. (2011). Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739–1740.   10.1093/bioinformatics/btr260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Liberzon A., Birger C., Thorvaldsdottir H., Ghandi M., Mesirov J. P., Tamayo P. (2015). The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425.   10.1016/j.cels.2015.12.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lin J. X., Leonard W. J. (2000). The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19, 2566–2576.   10.1038/sj.onc.1203523 [DOI] [PubMed] [Google Scholar]
  35. Lin N., Simon M. C. (2016). Hypoxia-inducible factors: key regulators of myeloid cells during inflammation. J. Clin. Invest. 126, 3661–3671.   10.1172/JCI84426 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Liu M., Fang L., Tan C., Long T., Chen H., Xiao S. (2011. a). Understanding Streptococcus suis serotype 2 infection in pigs through a transcriptional approach. BMC Genomics 12, 253.   10.1186/1471-2164-12-253 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Liu M., Tan C., Fang L., Xiao S., Chen H. (2011. b). Microarray analyses of THP-1 cells infected with Streptococcus suis serotype 2. Vet. Microbiol. 150, 126–131.   10.1016/j.vetmic.2010.12.014 [DOI] [PubMed] [Google Scholar]
  38. Liu T., Zhang L., Joo D., Sun S. C. (2017). NF-kappaB signaling in inflammation. Signal Transd. Targ. Ther. 2, 17023.   10.1038/sigtrans.2017.23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Livak K. J., Schmittgen T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408.   10.1006/meth.2001.1262 [DOI] [PubMed] [Google Scholar]
  40. Lun S., Perez-Casal J., Connor W., Willson P. J. (2003). Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2. Microb. Pathog. 34, 27–37.   10.1016/s0882-4010(02)00192-4 [DOI] [PubMed] [Google Scholar]
  41. Lun Z. R., Wang Q. P., Chen X. G., Li A. X., Zhu X. Q. (2007). Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect. Dis. 7, 201–209.   10.1016/S1473-3099(07)70001-4 [DOI] [PubMed] [Google Scholar]
  42. Meijerink M., Ferrando M. L., Lammers G., Taverne N., Smith H. E., Wells J. M. (2012). Immunomodulatory effects of Streptococcus suis capsule type on human dendritic cell responses, phagocytosis and intracellular survival. PloS One 7, e35849.   10.1371/journal.pone.0035849 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Mootha V. K., Lindgren C. M., Eriksson K. F., Subramanian A., Sihag S., Lehar J., et al. (2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273.   10.1038/ng1180 [DOI] [PubMed] [Google Scholar]
  44. Mortazavi A., Williams B. A., Mccue K., Schaeffer L., Wold B. (2008). Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621–628.   10.1038/nmeth.1226 [DOI] [PubMed] [Google Scholar]
  45. Mukandala G., Tynan R., Lanigan S., O’connor J. J. (2016). The Effects of Hypoxia and Inflammation on Synaptic Signaling in the CNS. Brain Sci. 6, 6.   10.3390/brainsci6010006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Nakayama T., Takeuchi D., Akeda Y., Oishi K. (2011). Streptococcus suis infection induces [corrected] bacterial accumulation in the kidney. Microb. Pathog. 50, 87–93.   10.1016/j.micpath.2010.11.005 [DOI] [PubMed] [Google Scholar]
  47. Okumura C. Y., Hollands A., Tran D. N., Olson J., Dahesh S., Von Kockritz-Blickwede M., et al. (2012). A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection. J. Mol. Med. (Berl) 90, 1079–1089.   10.1007/s00109-012-0882-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Perdomo-Celis F., Torres M. A., Ostos H., Gutierrez-Achury J., Molano V., Duran L. F., et al. (2015). Patterns of Local and Systemic Cytokines in Bacterial Meningitis and its Relation with Severity and Long-Term Sequelae. Biomark Insights 10, 125–131.   10.4137/BMI.S35005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Rashid F., Awan H. M., Shah A., Chen L., Shan G. (2017). Induction of miR-3648 Upon ER Stress and Its Regulatory Role in Cell Proliferation. Int. J. Mol. Sci. 18, 1375.   10.3390/ijms18071375 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Razooky B. S., Obermayer B., O’may J. B., Tarakhovsky A. (2017). Viral Infection Identifies Micropeptides Differentially Regulated in smORF-Containing lncRNAs. Genes (Basel) 8, 206.   10.3390/genes8080206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Rieckmann K., Seydel A., Szewczyk K., Klimke K., Rungelrath V., Baums C. G. (2018). Streptococcus suis cps7: an emerging virulent sequence type (ST29) shows a distinct, IgM-determined pattern of bacterial survival in blood of piglets during the early adaptive immune response after weaning. Vet. Res. 49, 48.   10.1186/s13567-018-0544-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A. S., Nizet V., et al. (2008). NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453, 807–811.   10.1038/nature06905 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Robinson J. T., Thorvaldsdottir H., Winckler W., Guttman M., Lander E. S., Getz G., et al. (2011). Integrative genomics viewer. Nat. Biotechnol. 29, 24–26.   10.1038/nbt.1754 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Rong J., Zhang W., Wang X., Fan H., Lu C., Yao H. (2012). Identification of candidate susceptibility and resistance genes of mice infected with Streptococcus suis type 2. PLoS One 7, e32150.   10.1371/journal.pone.0032150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Rozen S., Skaletsky H. (2000). Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365–386.   10.1385/1-59259-192-2:365 [DOI] [PubMed] [Google Scholar]
  56. Rungelrath V., Weisse C., Schutze N., Muller U., Meurer M., Rohde M., et al. (2018). IgM cleavage by Streptococcus suis reduces IgM bound to the bacterial surface and is a novel complement evasion mechanism. Virulence 9, 1314–1337.   10.1080/21505594.2018.1496778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Sanford S. E. (1987). Gross and histopathological findings in unusual lesions caused by Streptococcus suis in pigs. II. Central nervous system lesions. Can. J. Vet. Res. 51, 486–489. [PMC free article] [PubMed] [Google Scholar]
  58. Santos S., Andrade D. R. J. (2017). HIF-1alpha and infectious diseases: a new frontier for the development of new therapies. Rev. Inst. Med. Trop. Sao Paulo 59, e92.   10.1590/S1678-9946201759092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Schaffer K., Taylor C. T. (2015). The impact of hypoxia on bacterial infection. FEBS J. 282, 2260–2266.   10.1111/febs.13270 [DOI] [PubMed] [Google Scholar]
  60. Schaible B., Mcclean S., Selfridge A., Broquet A., Asehnoune K., Taylor C. T., et al. (2013). Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa. PLoS One 8, e56491.   10.1371/journal.pone.0056491 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Schaible B., Rodriguez J., Garcia A., Von Kriegsheim A., Mcclean S., Hickey C., et al. (2017). Hypoxia Reduces the Pathogenicity of Pseudomonas aeruginosa by Decreasing the Expression of Multiple Virulence Factors. J. Infect. Dis. 215, 1459–1467.   10.1093/infdis/jix139 [DOI] [PubMed] [Google Scholar]
  62. Schwerk C., Rybarczyk K., Essmann F., Seibt A., Molleken M. L., Zeni P., et al. (2010). TNFalpha induces choroid plexus epithelial cell barrier alterations by apoptotic and nonapoptotic mechanisms. J. BioMed. Biotechnol. 2010, 307231.   10.1155/2010/307231 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Schwerk C., Adam R., Borkowski J., Schneider H., Klenk M., Zink S., et al. (2011). In vitro transcriptome analysis of porcine choroid plexus epithelial cells in response to Streptococcus suis: release of pro-inflammatory cytokines and chemokines. Microbes Infect. 13, 953–962.   10.1016/j.micinf.2011.05.012 [DOI] [PubMed] [Google Scholar]
  64. Schwerk C., Papandreou T., Schuhmann D., Nickol L., Borkowski J., Steinmann U., et al. (2012). Polar Invasion and Translocation of Neisseria meningitidis and Streptococcus suis in a Novel Human Model of the Blood-Cerebrospinal Fluid Barrier. PLoS One 7, e30069.   10.1371/journal.pone.0030069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Segura M., Vadeboncoeur N., Gottschalk M. (2002). CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin. Exp. Immunol. 127, 243–254.   10.1046/j.1365-2249.2002.01768.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Segura M., Gottschalk M., Olivier M. (2004). Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis. Infect. Immun. 72, 5322–5330.   10.1128/IAI.72.9.5322-5330.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Segura M., Vanier G., Al-Numani D., Lacouture S., Olivier M., Gottschalk M. (2006). Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol. Med. Microbiol. 47, 92–106.   10.1111/j.1574-695X.2006.00067.x [DOI] [PubMed] [Google Scholar]
  68. Silva L. M., Baums C. G., Rehm T., Wisselink H. J., Goethe R., Valentin-Weigand P. (2006). Virulence-associated gene profiling of Streptococcus suis isolates by PCR. Vet. Microbiol. 115, 117–127.   10.1016/j.vetmic.2005.12.013 [DOI] [PubMed] [Google Scholar]
  69. Smith H. E., Damman M., Van Der Velde J., Wagenaar F., Wisselink H. J., Stockhofe-Zurwieden N., et al. (1999). Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect. Immun. 67, 1750–1756.   10.1128/IAI.67.4.1750-1756 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Strazielle N., Ghersi-Egea J. F. (2000). Choroid plexus in the central nervous system: biology and physiopathology. J. Neuropathol. Exp. Neurol. 59, 561–574.   10.1093/jnen/59.7.561 [DOI] [PubMed] [Google Scholar]
  71. Subramanian A., Tamayo P., Mootha V. K., Mukherjee S., Ebert B. L., Gillette M. A., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, 15545–15550.   10.1073/pnas.0506580102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Sumanovic-Glamuzina D., Culo F., Culo M. I., Konjevoda P., Jerkovic-Raguz M. (2017). A comparison of blood and cerebrospinal fluid cytokines (IL-1beta, IL-6, IL-18, TNF-alpha) in neonates with perinatal hypoxia. Bosn. J. Basic Med. Sci. 17, 203–210.   10.17305/bjbms.2017.1381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Taylor C. T., Colgan S. P. (2017). Regulation of immunity and inflammation by hypoxia in immunological niches. Nat. Rev. Immunol. 17, 774–785.   10.1038/nri.2017.103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Tenenbaum T., Matalon D., Adam R., Seibt A., Wewer C., Schwerk C., et al. (2008). Dexamethasone prevents alteration of tight junction-associated proteins and barrier function in porcine choroid plexus epithelial cells after infection with Streptococcus suis in vitro. Brain Res. 1229, 1–17.   10.1016/j.brainres.2008.06.118 [DOI] [PubMed] [Google Scholar]
  75. Tenenbaum T., Papandreou T., Gellrich D., Friedrichs U., Seibt A., Adam R., et al. (2009). Polar bacterial invasion and translocation of Streptococcus suis across the blood-cerebrospinal fluid barrier in vitro. Cell Microbiol. 11, 323–336.   10.1111/j.1462-5822.2008.01255.x [DOI] [PubMed] [Google Scholar]
  76. van der Flier M., Geelen S. P., Kimpen J. L., Hoepelman I. M., Tuomanen E. I. (2003). Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin. Microbiol. Rev. 16, 415–429.   10.1128/cmr.16.3.415-429.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Vecht U., Wisselink H. J., Van Dijk J. E., Smith H. E. (1992). Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype. Infect. Immun. 60, 550–556.   10.1128/IAI.60.2.550-556.1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Williams A. E., Blakemore W. F. (1990). Pathogenesis of meningitis caused by Streptococcus suis type 2. J. Infect. Dis. 162, 474–481.   10.1093/infdis/162.2.474 [DOI] [PubMed] [Google Scholar]
  79. Wolburg H., Wolburg-Buchholz K., Liebner S., Engelhardt B. (2001). Claudin-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse. Neurosci. Lett. 307, 77–80.   10.1016/s0304-3940(01)01927-9 [DOI] [PubMed] [Google Scholar]
  80. Wu Z., Zhang W., Lu Y., Lu C. (2010). Transcriptome profiling of zebrafish infected with Streptococcus suis. Microb. Pathog. 48, 178–187.   10.1016/j.micpath.2010.02.007 [DOI] [PubMed] [Google Scholar]
  81. Ye M. H., Bao H., Meng Y., Guan L. L., Stothard P., Plastow G. (2017). Comparative transcriptomic analysis of porcine peripheral blood reveals differentially expressed genes from the cytokine-cytokine receptor interaction pathway related to health status. Genome 60, 1021–1028.   10.1139/gen-2017-0074 [DOI] [PubMed] [Google Scholar]
  82. Zeitouni N. E., Chotikatum S., Von Kockritz-Blickwede M., Naim H. Y. (2016). The impact of hypoxia on intestinal epithelial cell functions: consequences for invasion by bacterial pathogens. Mol. Cell Pediatr. 3, 14.   10.1186/s40348-016-0041-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Zhang D. Y., Zou X. J., Cao C. H., Zhang T., Lei L., Qi X. L., et al. (2018). Identification and Functional Characterization of Long Non-coding RNA MIR22HG as a Tumor Suppressor for Hepatocellular Carcinoma. Theranostics 8, 3751–3765.   10.7150/thno.22493 [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Zheng Y., Stamminger T., Hearing P. (2016). E2F/Rb Family Proteins Mediate Interferon Induced Repression of Adenovirus Immediate Early Transcription to Promote Persistent Viral Infection. PLoS Pathog. 12, e1005415.   10.1371/journal.ppat.1005415 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Zinkernagel A. S., Peyssonnaux C., Johnson R. S., Nizet V. (2008). Pharmacologic augmentation of hypoxia-inducible factor-1alpha with mimosine boosts the bactericidal capacity of phagocytes. J. Infect. Dis. 197, 214–217.   10.1086/524843 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://www.ncbi.nlm.nih.gov/, PRJNA533919; https://www.ncbi.nlm.nih.gov/, PRJNA533792; https://www.ncbi.nlm.nih.gov/, PRJNA534398.


Articles from Frontiers in Cellular and Infection Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES